James Patrick Tursi
CIK 1527710 · Executive VP, Global R&D · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
7
Total Filings
38
Lifetime Open-Market Net
-$2.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MetaVia Inc. (NRBO) Delisted | Director | 20,568 | $2.36 | $48.5K | $0 | 4 | 2026-06-08 |
| Endo International plc (ENDP) Delisted | Executive VP, Global R&D | 0 | $0.29 | $0 | $0 | 1 | 2022-08-17 |
| AGILE THERAPEUTICS INC (AGRX) Delisted | Director | 2,066 | $1.51 | $3.1K | $0 | 9 | 2022-06-10 |
| ANTARES PHARMA, INC. (ATRS) Delisted | EVP, Chief Medical Officer | 45,205 | $5.59 | $252.7K | $0 | 2 | 2019-06-14 |
| Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Chief Medical Officer | 242,052 | — | — | $24.6K | 10 | 2018-05-16 |
| POZEN INC /NC (POZN) Delisted | Chief Medical Officer | 30,637 | — | — | $0 | 1 | 2015-12-30 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Chief Medical Officer | 0 | — | — | -$2.95M | 11 | 2015-01-30 |
Recent Filings · Page 3 of 4
38 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-05-18 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Buy (P) | +4,500 | $17.0K | EDGAR |
| 2016-03-18 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Grant (A) | +47,368 | $0 | EDGAR |
| 2016-02-17 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Grant (A) | +86,863 | $0 | EDGAR |
| 2016-02-09 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Other (J) | +30,637 | $0 | EDGAR |
| 2015-12-30 | POZEN INC /NC (POZN) Delisted | Grant (A) | +29,137 | $0 | EDGAR |
| 2015-06-10 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-30 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Other (J) | −32,634 | -$1.07M | EDGAR |
| 2014-11-26 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Mixed | −3,151 | -$266.0K | EDGAR |
| 2014-11-24 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Mixed | −3,648 | -$1.28M | EDGAR |
| 2014-10-02 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.